We provide diagnostic testing for breast cancer patients to better personalize their treatment.
The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient’s tumor in order to optimize cancer treatment decisions.
More than 1 million patients around the world have relied on the Oncotype DX tests for breast cancers to make better-informed treatment choices.